StudyID: SVA-4, atrial fibrillation
DISEASE INTERVENTION COMPARISON RESULTS
J Cardiovasc Electrophysiol. 2008 Feb;19(2):172-7 Randomized Controlled Trial
IN StudyID: SVA-4, atrial fibrillation The Use of
azimilide
As Treatment, Chronic
Is equal Than
placebo
To modify, at 6 months, mortality or Af recurrence, while increasing adverse effects and pro-arrhythmia